Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer

International Journal of Cancer

Volumn 118, Issue 6, 2006, Pages 1364-1369

  Kraunz, Kim S ^a   Nelson, Heather H ^a   Lemos, Miriam ^a   Godleski, John J ^a   Wiencke, John K ^b   Kelsey, Karl T ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Homozygous deletion; Mutation; NSCLC; p16INK4a; Tobacco

Indexed keywords

ASBESTOS; BRCA1 PROTEIN; CARCINOGEN; DNA; DOUBLE STRANDED DNA; PROTEIN P16INK4A; RETINOBLASTOMA PROTEIN;

AGED; ARTICLE; CANCER STAGING; CANCER SUSCEPTIBILITY; CODON; DNA EXTRACTION; DNA METHYLATION; DNA STRAND BREAKAGE; FEMALE; GENE DELETION; GENE INACTIVATION; GENE SILENCING; HOMOZYGOUS DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS; TOBACCO; ADENOCARCINOMA; ANALYSIS OF VARIANCE; GENETICS; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; OCCUPATIONAL EXPOSURE; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; ASBESTOS; BRCA1 PROTEIN; CARCINOGENS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM STAGING; OCCUPATIONAL EXPOSURE; SMOKING;

EID: 33644502525     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21522     Document Type: Article

References (34)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Parkin DM, Pisani P, Lopez AD, Masuyer E. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 1994;59:494-504.
3. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol 2005;23:3175-85.
4. Sarkar FH, Li Y, Vallyathan V. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners. Int J Mol Med 2001;8:453-9.
5. Yoshino I, Fukuyama S, Kameyama T, Shikada Y, Oda S, Maehara Y, Sugimachi K. Detection of loss of heterozygosity by high-resolution fluorescent system in non-small cell lung cancer: association of loss of heterozygosity with smoking and tumor progression. Chest 2003;123:545-50.
6. Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Cancer Res 2001;61:612-15.
7. Zhao Y, Wu D, Xiang X, Zhang B, Zhou N, Hu Y. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Chin Med Sci J 1999;14:134-7.
8. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101:13306-11.
9. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
10. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
11. INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers. Br J Cancer 1999;81:696-701.
12. Brambilla C, Fievet F, Jeanmart M, de Fraipont F, Lantuejoul S, Frappat V, Ferretti G, Brichon PY, Moro-Sibilot D. Early detection of lung cancer: role of biomarkers. Eur Respir J Suppl 2003;39:36s-44s.
13. Xue Q, Sano T, Kashiwabara K, Saito M, Oyama T, Nakajima T. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung. Pathol Int 2002;52:103-9.
14. Xue Q, Sano T, Kashiwabara K, Oyama T, Nakajima T. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung. Jpn J Cancer Res 2001;92:285-92.
15. INK4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res 1999;5:791-800.
16. INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001;61:3419-24.
17. Soria JC, Rodriguez M, Liu DD, Lee JJ, Hong WK, Mao L. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res 2002;62:351-5.
18. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-7.
19. Toyooka S, Suzuki M, Tsuda T, Toyooka KO, Maruyama R, Tsukuda K, Fukuyama Y, Iizasa T, Fujisawa T, Shimizu N, Minna JD, Gazdar AF. Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int J Cancer 2004;110:462-4.
20. Zochbauer-Muller S, Lam S, Toyooka S, Virmani AK, Toyooka KO, Seidl S, Minna JD, Gazdar AF. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 2003;107:612-16.
21. Carter TL, Reaman GH, Kees UR. INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reaction. Br J Haematol 2001;113:323-8.
22. INK4A inactiyation in non small-cell lung cancers. Oncogene 1998;16:497-504.
23. Iwato M, Tachibana O, Tohma Y, Arakawa Y, Nitta H, Hasegawa M, Yamashita J, Hayashi Y. Alterations of the INK4a/ARF locus in human intracranial germ cell tumors. Cancer Res 2000;60:2113-15.
24. Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J Cancer 1995;61:115-20.
25. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
26. Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004;23:1000-4.
27. Nelson HH, Kelsey KT. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene 2002;21:7284-8.
28. Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 1998;58:1804-7.
29. Cloos J, Braakhuis BJ, Steen I, Copper MP, de Vries N, Nauta JJ, Snow GB. Increased mutagen sensitivity in head-and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 1994;56:816-19.
30. Schantz SP, Hsu TC, Ainslie N, Moser RP. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 1989;262:3313-15.
31. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, Schantz SP. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 1989;49:4626-8.
32. Wu X, Hsu TC, Spitz MR. Mutagen sensitivity exhibits a dose-response relationship in case-control studies. Cancer Epidemiol Biomarkers Prev 1996;5:577-8.
33. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L, Westra WH, Yang SC, Jen J, Sidransky D. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 2001;61:1309-13.
34. Dusinska M, Collins A, Kazimirova A, Barancbkova M, Harrington V, Volkovova K, Staruchova M, Horska A, Wsolova L, Kocan A, Petrik J, Machata M, et al. Genotoxic effects of asbestos in humans. Mutat Res 2004;553:91-102.